| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |